Headache 

Read the Online Editorial Team's picks for the April 2012 issue:

The Development of a Survey to Measure Completeness of Response to Migraine Therapy
Coon C, Fehnel S, Davis K, Runken MC, Beach ME, Cady R.
Coon and colleagues assess the psychometric properties of a patient-reported migraine instrument, the Completeness of Response Survey (CORS). The survey is intended to measure a comprehensive set of important patient decision-making factors regarding the initiation and continuation of treatment. As new treatments move towards complete and consistent migraine relief, this study contends more comprehensive instruments, such as CORS, are needed to demonstrate those benefits.

Combined Hormonal Contraceptives: Is It Time To Reassess their Role in Migraine?
Calhoun A.
In a comprehensive review article by Calhoun, risks, benefits and the divergent findings in the literature of an extensive array of hormonal contraceptives – particularly with regard to stroke risk – are assessed. As explored in this paper, traditional positions on the potential stroke risk associated with using combined hormonal contraceptives (CHC) may be shifting. With such a shift in risk/benefit analyses, Calhoun contends it is time to reassess the role of CHC’s in migraine both with and without aura.

• Abstracts and Citations
• Published online on May 25, 2012

• Dihydroergotamine (DHE) Use During Gestation and the Risk of Adverse Pregnancy Outcomes
• Published online on May 21, 2012

• Concurrent OnabotulinumtoxinA Treatment of Cervical Dystonia and Concomitant Migraine
• Published online on May 18, 2012